ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,073Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 559

$374K Total Retail Price of All Prescriptions

Rank: 74 out of 559

625 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 625 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 625 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,293 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 711 615 1 1
LEVOTHYROXINE SODIUM 527 481 2 2
HYDROCHLOROTHIAZIDE 412 343 3 8
METFORMIN HCL 355 311 4 5
AMLODIPINE BESYLATE 303 269 5 6
OMEPRAZOLE 303 235 5 4
SIMVASTATIN 288 236 7 3
HYDROCODONE-ACETAMINOPHEN 235 122 S3 8 7
IBUPROFEN 227 150 9 30
PRAVASTATIN SODIUM 224 197 10 35
LOVASTATIN 223 203 11 10
ZOLPIDEM TARTRATE 186 106 12 17
ATENOLOL 148 128 13 15
GLIPIZIDE 135 116 14 31
ALENDRONATE SODIUM 129 119 15 13
ACETAMINOPHEN-CODEINE 127 101 S3 16 83
SERTRALINE HCL 123 118 17 19
PROAIR HFA 112 76 18 29
TRAMADOL HCL 112 79 18 27
GABAPENTIN 102 70 20 9
RANITIDINE HCL 101 84 21 26
FUROSEMIDE 100 81 22 11
CITALOPRAM HBR 97 55 23 21
PANTOPRAZOLE SODIUM 95 74 24 41
PEN NEEDLE 87 74 25 150
DONEPEZIL HCL 85 85 26 36
GLIMEPIRIDE 83 63 27 53
TRAZODONE HCL 81 58 28 28
LOSARTAN POTASSIUM 72 66 29 14
AZITHROMYCIN 72 59 29 39
METOPROLOL SUCCINATE 67 66 31 16
AMITRIPTYLINE HCL 66 40 R 32 58
FLUTICASONE PROPIONATE 64 53 33 22
OXYBUTYNIN CHLORIDE 62 55 34 62
MELOXICAM 61 45 35 42
DILTIAZEM ER 61 59 35 118
LEVEMIR FLEXPEN 60 58 37 127
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 51 38 18
CLONIDINE HCL 57 49 38 68
METOPROLOL TARTRATE 51 51 40 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.